Your browser doesn't support javascript.
loading
Generation of three isogenic control lines from patient-derived iPSCs carrying bi-allelic ABCA4 variants underlying Stargardt disease.
Karjosukarso, Dyah W; Bukkems, Femke; Duijkers, Lonneke; Leijsten, Nico; Collin, Rob W J.
Afiliación
  • Karjosukarso DW; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Bukkems F; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Duijkers L; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Leijsten N; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Collin RWJ; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: rob.collin@radboudumc.nl.
Stem Cell Res ; 71: 103169, 2023 09.
Article en En | MEDLINE | ID: mdl-37480818
ABSTRACT
Stargardt disease, a progressive retinal disorder, is associated with bi-allelic variants in ABCA4. Employing the CRISPR/Cas9 approach, we generated isogenic control lines (RMCGENi005-A-1, RMCGENi018-A-1, RMCGENi017-A-1) for each of three induced pluripotent stem cell lines (RMCGENi005-A, RMCGENi018-A, RMCGENi017-A) derived from Stargardt patients carrying compound heterozygous ABCA4 variants. All of the generated lines showed pluripotent characteristics, no chromosomal aberrations and no indication of off-targets. The availability of these isogenic control lines will allow us to have a fair comparison between health and disease state within our studies on Stargardt disease.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Madre Pluripotentes Inducidas Límite: Humans Idioma: En Revista: Stem Cell Res Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Madre Pluripotentes Inducidas Límite: Humans Idioma: En Revista: Stem Cell Res Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos